TMCnet News
Stock to Watch: Inovio Biomedical Down 5.9% (INO)Feb 06, 2012 (SmarTrend(R) Spotlight via COMTEX) -- Inovio Biomedical (AMEX:INO) is one of today's worst performing penny stocks, down 5.9% to $0.64 on 1.0x average daily volume. Inovio Biomedical has traded 734,000 shares thus far today, vs. average volume of 728,000 shares per day. The stock has underperformed the Dow (-8.0% to the Dow's -0.4%) and underperformed the S&P 500 (-8.0% to the S&P's -0.2%) during today's trading. Inovio Biomedical Corporation is focused on developing multiple DNA-based immunotherapies. The Company develops applications of electroporation using brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceutical. There is potential upside of 254.3% for shares of Inovio Biomedical based on a current price of $0.64 and an average consensus analyst price target of $2.25. Inovio Biomedical shares should encounter resistance at the 200-day moving average (MA) of $0.64 and support at the 50-day MA of $0.46. In the past 52 weeks, shares of Inovio Biomedical have traded between a low of $0.35 and a high of $1.50 and are now at $0.64, which is 81% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.1% while the 50-day MA has advanced 1.7%. SmarTrend is monitoring the recent change of momentum in Inovio Biomedical. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Inovio Biomedical in search of a potential trend change. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |
